Singapore-headquartered HCC Healthcare plans to continue expansion of its integrated medical and aged care services across Asia after signing a business combination agreement with Nasdaq-listed special purpose acquisition company RF Acquisition Corp III.
The proposed transaction values HCC Healthcare at approximately US$500 million and is expected to provide the company with access to public capital markets to support growth across Asia, including the Japanese market.
Subject to shareholder and regulatory approvals, the transaction is expected to close in the fourth quarter of 2026.
In a statement, HCC Healthcare said it was building one of Taiwan’s largest integrated medical and long-term care networks – encompassing affiliated hospitals, clinics, pharmacies, rehabilitation centres, dialysis services, and long-term care facilities as well as home and community-based care.
According to the company, its network currently includes more than 120 long-term care facilities with over 9,000 beds, while community and home care services support more than 7,000 people through case management programs.
AI ENABLED
HCC Healthcare said it had developed a proprietary AI platform designed to support both clinical and operational decision-making across its services.
The platform combines multimodal healthcare data, spatial intelligence and causal inference technologies to help improve care delivery and resource allocation.
The company said integrating medical and long-term care data would allow it to deliver more personalised care while improving operational efficiency across its network.
GROWTH PHASE
HCC chairman and CEO George Hsu said the proposed Nasdaq listing would support the company’s next phase of growth.
“Our mission has always been to build a healthcare ecosystem that seamlessly integrates medical treatment, long-term care, and community services,” Mr Hsu said.
“This transaction provides us with a strong foundation to scale our integrated care model, accelerate digital innovation, and expand our footprint across Asia.”
RF Acquisition chairman and CEO Tse Meng Ng said ageing populations across Asia were creating significant demand for integrated care models.
“HCC Healthcare has built one of Taiwan’s leading integrated healthcare platforms by combining hospitals, clinics, long-term care facilities and community services with advanced digital capabilities,” Mr Ng said.
“We believe the company’s technology-enabled approach to integrated care positions it well to capitalise on the long-term demographic trends across the region.”
GROWING DEMAND
HCC Healthcare said Taiwan, Japan and many other Asian economies were rapidly becoming super-aged societies, creating growing demand for coordinated healthcare and long-term care services.
Proceeds from the transaction would support initiatives including consolidating its healthcare ecosystem into a unified platform, expanding into the Japanese market, accelerating AI-enabled care, pursuing wellness partnerships and advancing precision and regenerative medicine.
The transaction remains subject to approval by RF Acquisition shareholders, the effectiveness of a registration statement to be filed with the US Securities and Exchange Commission, and other customary closing conditions.
Add Comment